Vigiliant Marks Milestone Certification

Vigiliant Marks Milestone Certification December 11, 2014 Vigilant Biosciences has received International Organization for Standardization (ISO) 13485:2003 certification, an internationally recognized quality standard for medical devices. The certification covers the design, development, production, sales, and service of Vigilant’s OncAlert oral cancer-specific risk assessment products. This certification demonstrates that Vigilant has successfully implemented a quality management

Vigilant Biosciences, Inc. Marks Significant Milestone with ISO 13485:2003 Certification

Vigilant Biosciences, Inc. Marks Significant Milestone with ISO 13485:2003 Certification December 10, 2014 MIAMI, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading developer of solutions that aid in the early detection and intervention of cancer, today announced that it has received ISO 13485:2003 certification, an internationally recognized quality standard for medical devices. The ISO 13485:2003 certification

State Universities Should Be Drivers of Tomorrow’s ‘Innovation Economy’

State Universities Should Be Drivers of Tomorrow’s ‘Innovation Economy’ June 26, 2017 After witnessing the effects of oral cancer on his parents, Matthew Kim knew he wanted to do something to spare others from the pain and disfigurement associated with this potentially life-threatening disease. His mother endured multiple surgeries and treatments, ultimately beating the disease

© 2020 Vigilant Biosciences

Follow Us

3900001 Rev2